Salvage radical prostatectomy for radiorecurrent prostate cancer: Indications and results

European Journal of Surgical Oncology

Volumn 32, Issue 9, 2006, Pages 964-969

  Darras, J ^a   Joniau, S ^a   Van Poppel, H ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Biochemical failure; Local recurrence; Radiorecurrent prostate cancer; Salvage radical prostatectomy

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLADDER NECK STENOSIS; BRACHYTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; ENDOSCOPIC SURGERY; EXPERIENCE; FOLLOW UP; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; IMPOTENCE; INTERMETHOD COMPARISON; MALE; MEDICAL EXPERT; MEDICAL LITERATURE; MORBIDITY; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENT CANCER; STRESS INCONTINENCE; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; COMBINED MODALITY THERAPY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33750332935     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.05.015     Document Type: Article

References (28)

1. Mettlin C.J., Murphy G.P., McDonald C.J., and Menck H.R. The National Cancer Data Base report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer 86 (1999) 1877-1882
2. Stephenson R.A. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database. Urol Clin North Am 29 (2002) 173-181
3. Chen B.T., and Wood Jr. D.P. Salvage prostatectomy in patients who have failed radiation therapy or cryotherapy as primary treatment for prostate cancer. Urology 62 (2003) 69-78
4. Kuban D.A., el-Mahdi A.M., and Schellhammer P.F. Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 32 (1995) 307-316
5. D'Amico A.V., Cote K., Loffredo M., Renshaw A.A., and Schultz D. Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer. J Clin Oncol 20 (2002) 4567-4573
6. Kupelian P.A., Buchsbaum J.C., Patel C., et al. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Int J Radiat Oncol Biol Phys 52 (2002) 704-711
7. Shipley W.U., Thames H.D., Sandler H.M., et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 281 (1999) 1598-1604
8. Pisters L.L. Salvage radical prostatectomy: refinement of an effective procedure. Semin Radiat Oncol 13 (2003) 166-174
9. Eastham J.A., and Scardino P.T. Salvage radical prostatectomy. Contemp Urol 16 (2004) 34
10. Lee W.R., Hanks G.E., and Hanlon A. Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol 15 (1997) 230-238
11. Pollack A., Zagars G.K., and Kavadi V.S. Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer. Cancer 74 (1994) 670-678
12. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus Statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
13. Djavan B., Moul J.W., Zlotta A., Remzi M., and Ravery V. PSA progression following radical prostatectomy and radiation therapy: new standards in the new millennium. Eur Urol 43 (2003) 12-27
14. Shekarriz B., Upadhyay J., and Pontes J.E. Salvage radical prostatectomy. Urol Clin North Am 28 (2001) 545-553
15. Crook J., Malone S., Perry G., Bahadur Y., Robertson S., and Abdolell M. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys 48 (2000) 355-367
16. Touma N.J., Izawa J.I., and Chin J.L. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol 173 (2005) 373-379
17. Crook J.M., Perry G.A., Robertson S., and Esche B.A. Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients. Urology 45 (1995) 624-631
18. Kahn D., Williams R.D., Haseman M.K., Reed N.L., Miller S.J., and Gerstbrein J. Radioimmunoscintigraphy With In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy. J Clin Oncol 16 (1998) 284-289
19. Reiner W.G., and Walsh P.C. An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery. J Urol 121 (1979) 198-200
20. Van Poppel H., Goethuys H., Callewaert P., Vanuytsel L., Van de Voorde W., and Baert L. Radical prostatectomy can provide a cure for well-selected clinical stage T3 prostate cancer. Eur Urol 38 (2000) 372-379
21. Rogers E., Ohori M., Kassabian V.S., Wheeler T.M., and Scardino P.T. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 153 (1995) 104-110
22. Amling C.L., Lerner S.E., Martin S.K., Slezak J.M., Blute M.L., and Zincke H. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 161 (1999) 857-862
23. Gheiler E.L., Tefilli M.V., Tiguert R., et al. Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. Urology 51 (1998) 789-795
24. Masterson T.A., Stephenson A.J., Scardino P.T., and Eastham J.A. Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Urology 66 (2005) 623-626
25. Stephenson A.J., Scardino P.T., Bianco Jr. F.J., Diblasio C.J., Fearn P.A., and Eastham J.A. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172 (2004) 2239-2243
26. Pisters L.L., Perrotte P., Scott S.M., Greene G.F., and Von Eschenbach A.C. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J Clin Oncol 17 (1999) 2514-2520
27. Chin J.L., Pautler S.E., Mouraviev V., Touma N., Moore K., and Downey D.B. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 165 (2001) 1937-1941
28. Grado G.L., Collins J.M., Kriegshauser J.S., et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53 (1999) 2-10